SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+8.42%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$160M
AUM Growth
+$160M
(+14%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
7.29%
Top 10 Holdings %
Top 10 Hldgs %
27.73%
Holding
76
New
19
Increased
19
Reduced
25
Closed
10
Top Buys
| 1 |
Elevance Health
ELV
|
$3.45M |
| 2 |
TMH
Team Health Holdings Inc
TMH
|
$3.11M |
| 3 |
Amgen
AMGN
|
$3.08M |
| 4 |
Labcorp
LH
|
$2.95M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$2.71M |
Top Sells
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$3.14M |
| 2 |
UnitedHealth
UNH
|
$2.64M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
$2.31M |
| 4 |
DaVita
DVA
|
$2.22M |
| 5 |
Cigna
CI
|
$2.19M |
Sector Composition
| 1 | Healthcare | 89.14% |
| 2 | Financials | 2.09% |
| 3 | Industrials | 0.78% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVHC
26
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.71M | 1.69% |
+80,000
| New | +$2.71M |
|
27
Viatris
VTRS
$12.3B
| $2.69M | 1.68% |
+55,000
| New | +$2.69M |
|
28
CVS Health
CVS
$93.7B
| $2.6M | 1.63% |
34,780
-15,220
| -30% | -$1.14M |
|
29
Owens & Minor
OMI
$402M
| $2.42M | 1.51% |
+68,940
| New | +$2.42M |
|
30
Boston Scientific
BSX
$158B
| $2.39M | 1.49% |
176,950
-23,050
| -12% | -$312K |
|
|
FRX
31
DELISTED
FOREST LABORATORIES INC
FRX
| $2.31M | 1.44% |
25,000
-25,000
| -50% | -$2.31M |
|
32
Quest Diagnostics
DGX
$20.1B
| $2.23M | 1.39% |
+38,532
| New | +$2.23M |
|
|
COV
33
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $2.21M | 1.38% |
+30,000
| New | +$2.21M |
|
|
HSP
34
DELISTED
HOSPIRA INC
HSP
| $2.16M | 1.35% |
50,000
+10,000
| +25% | +$433K |
|
35
Biogen
BIIB
$20.3B
| $2.14M | 1.34% |
7,000
-3,000
| -30% | -$918K |
|
|
UAM
36
DELISTED
Universal American Corp
UAM
| $2.12M | 1.32% |
300,000
+267,375
| +820% | +$1.89M |
|
37
Regeneron Pharmaceuticals
REGN
$60.8B
| $2.1M | 1.31% |
+7,000
| New | +$2.1M |
|
|
AGN
38
DELISTED
Allergan plc
AGN
| $2.06M | 1.29% |
10,000
-3,000
| -23% | -$618K |
|
39
Revvity
RVTY
$10.1B
| $2.03M | 1.27% |
45,000
-15,000
| -25% | -$676K |
|
40
Bruker
BRKR
$5.01B
| $2.02M | 1.26% |
88,400
+18,400
| +26% | +$419K |
|
|
SCAI
41
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $1.96M | 1.23% |
+63,872
| New | +$1.96M |
|
|
STJ
42
DELISTED
St Jude Medical
STJ
| $1.96M | 1.22% |
30,000
-10,000
| -25% | -$654K |
|
43
Agilent Technologies
A
$35.3B
| $1.96M | 1.22% |
35,000
-15,000
| -30% | -$839K |
|
|
TRNX
44
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $1.91M | 1.19% |
90,000
-19,000
| -17% | -$403K |
|
|
MNK
45
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $1.87M | 1.17% |
29,510
-490
| -2% | -$31.1K |
|
46
Thermo Fisher Scientific
TMO
$184B
| $1.8M | 1.13% |
15,000
-15,000
| -50% | -$1.8M |
|
47
Gilead Sciences
GILD
$140B
| $1.77M | 1.11% |
25,000
-20,000
| -44% | -$1.42M |
|
|
CPHD
48
DELISTED
Cepheid Inc
CPHD
| $1.55M | 0.97% |
30,000
| – | – |
|
49
Illumina
ILMN
$15.4B
| $1.49M | 0.93% |
+10,000
| New | +$1.49M |
|
|
ENDP
50
DELISTED
Endo International plc
ENDP
| $1.37M | 0.86% |
20,000
-10,000
| -33% | -$687K |
|